Our bodies are not cut out for the downsides of a modern lifestyle. As a result, kidney disease and conditions like hypertension and diabetes are on the rise. The cost for society and the individual are huge.
The problem is that kidney disease is often discovered (too) late, and many companies are seeking ways of making earlier detection possible. We continue to successfully apply our significant expertise in fluorescence flow cytometry in urinalysis. It is one of few technologies with which one can derive effective results in the clinically relevant, low concentration ranges. And there is a huge untapped potential for the technology that promises several new, sought-after applications moving forward.
With representative sites in nearly all countries, our supply and service are leading in our field. Our solutions address the smallest laboratories to large-scale workflow design.